Viewing Study NCT07233720


Ignite Creation Date: 2025-12-25 @ 4:28 AM
Ignite Modification Date: 2025-12-26 @ 3:31 AM
Study NCT ID: NCT07233720
Status: RECRUITING
Last Update Posted: 2025-11-18
First Post: 2025-07-08
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Zanubrutinib Combined With Rituximab in the Treatment for Patients With Marginal Zone Lymphoma
Sponsor: Henan Cancer Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module